KalosM., LevineB.L., PorterD.L., KatzS., GruppS.A., BaggA., JuneC.H.2011. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced Leukemia. Sci Transl Med., 3:95ra73.
2.
KetzerP., HaasS.F., EngelhardtS., HartigJ.S., NettelbeckD.M.2012. Synthetic riboswitches for external regulation of genes transferred by replication-deficient and oncolytic adenoviruses. Nucleic Acids Res.(in press).
3.
MakinoH., AokiM., HashiyaN., YamasakiK., AzumaJ., SawaY., KanedaY., OgiharaT., MorishitaR.2012. Long-term follow-up evaluation of results from clinical trial using hepatocyte growth factor gene to treat severe peripheral arterial disease. Arterioscler Thromb Vasc Biol., 32:2503–2509.
4.
PorterD.L., LevineB.L., KalosM., BaggA., JuneC.H.2011. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med., 365:725–733.
